InhalPlus
InhalPlus is developing a technology that enables medication to be administered via the airways during artificially supported breathing.
InhalPlus has raised €500k across 1 funding round from 1 investor, most recently a Pre-Seed round in Oct 2026. Based in Hanover, Germany; active in Healthtech. Data as of 28 Oct 2026.
Hanover, Germanyinhalplus.com ↗
Total raised
€500k
€500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDInhalPlus — funding by year — interactive chart.
Data table
| InhalPlus — funding by year | |
|---|---|
| 2026 | €500k |
Signals
High confidenceRaise-next likelihood8
base rate 24% for Pre-Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-26 | Pre-Seed | €500k | NBank Capital | View deal → |
Investors
1Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData